Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12307768 | PMC |
| http://dx.doi.org/10.1038/s41419-025-07761-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: CXCL13 suppresses liver regeneration through the negative regulation of HGF signaling.
Cell Death Dis
July 2025
Department of Gastroenterology, Taihe Hospital, School of Basic Medical Sciences, Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.
Background: The issue of human mental health is gaining more and more attention nowadays. However, most mental disorders are treated with antipsychotic drugs that cause weight gain and metabolic disorders, which include olanzapine (OLZ). The search for and development of natural compounds for the prevention of obesity when taking antipsychotic drugs is an urgent task.
View Article and Find Full Text PDFClinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature.
Diagn Pathol
August 2024
Department of Pathology, Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Article Synopsis
- Lennert lymphoma (LL) is a rare type of peripheral T-cell lymphoma that is often misdiagnosed due to unclear diagnostic criteria; careful examination of cytomorphology and immunohistochemistry is crucial for accurate diagnosis.
- A case study highlights a patient diagnosed with LL through these methods, showing small to medium-sized CD4(+) T cells and no indicators of other T cell types, with notable histiocytes and EBV(+) cells present.
- The patient achieved complete remission after chemotherapy and remained disease-free for five years, indicating that accurate diagnosis and treatment can lead to positive outcomes in LL cases.
Publisher Correction: Interferon subverts an AHR-JUN axis to promote CXCL13 T cells in lupus.
Nature
August 2024
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases.
Front Immunol
October 2022
National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, and State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, China.
[This corrects the article DOI: 10.3389/fimmu.2022.
View Article and Find Full Text PDF